1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. North America Organoids Services Market Landscape

4.1 PEST Analysis

5. North America Organoids Services Market - Key Market Dynamics

5.1 North America Organoids Services Market - Key Market Dynamics

5.2 Market Drivers

5.2.1 Increasing Demand for Innovative Drug Screening Services

5.2.2 Surge in Popularity of Personalized Drugs

5.3 Market Restraints

5.3.1 Dearth of Skilled Professionals

5.4 Market Opportunities

5.4.1 Increasing Key Developments

5.5 Future Trends

5.5.1 Integration of Artificial Intelligence

5.6 Impact of Drivers and Restraints:

6. North America Organoids Services Market - Analysis

6.1 North America Organoids Services Market Revenue (US$ Million), 2021-2031

6.2 North America Organoids Services Market Forecast Analysis

7. North America Organoids Services Market Analysis - by Type

7.1 Intestine

7.1.1 Overview

7.1.2 Intestine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Liver

7.2.1 Overview

7.2.2 Liver: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Stomach

7.3.1 Overview

7.3.2 Stomach: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Pancreas

7.4.1 Overview

7.4.2 Pancreas: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Lung

7.5.1 Overview

7.5.2 Lung: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Brain

7.6.1 Overview

7.6.2 Brain: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Kidney

7.7.1 Overview

7.7.2 Kidney: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Organoids Services Market Analysis - by Application

8.1 Developmental Biology Disease

8.1.1 Overview

8.1.2 Developmental Biology Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Pathology of Infectious Disease

8.2.1 Overview

8.2.2 Pathology of Infectious Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Regenerative Medicine

8.3.1 Overview

8.3.2 Regenerative Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Drug Toxicity and Efficacy Testing

8.4.1 Overview

8.4.2 Drug Toxicity and Efficacy Testing: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Drug Discovery and Personalized Medicine

8.5.1 Overview

8.5.2 Drug Discovery and Personalized Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Organoids Services Market Analysis - by Source

9.1 Pluripotent Stem Cells

9.1.1 Overview

9.1.2 Pluripotent Stem Cells: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Organ Specific Adult Stem Cell

9.2.1 Overview

9.2.2 Organ Specific Adult Stem Cell: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Organoids Services Market - Country Analysis

10.1 North America

10.1.1 North America Organoids Services Market - Revenue and Forecast Analysis - by Country

10.1.1.1 North America Organoids Services Market - Revenue and Forecast Analysis - by Country

10.1.1.2 United States: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.2.1 United States: North America Organoids Services Market Share - by Type

10.1.1.2.2 United States: North America Organoids Services Market Share - by Application

10.1.1.2.3 United States: North America Organoids Services Market Share - by Source

10.1.1.3 Canada: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.3.1 Canada: North America Organoids Services Market Share - by Type

10.1.1.3.2 Canada: North America Organoids Services Market Share - by Application

10.1.1.3.3 Canada: North America Organoids Services Market Share - by Source

10.1.1.4 Mexico: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.4.1 Mexico: North America Organoids Services Market Share - by Type

10.1.1.4.2 Mexico: North America Organoids Services Market Share - by Application

10.1.1.4.3 Mexico: North America Organoids Services Market Share - by Source

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Organoids Services Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Sino Biological Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Eurofins Scientific SE

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Molecular Devices, LLC.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 InSphero

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Cyprio

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 InnoSer

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 LABTOO

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 CUSABIO TECHNOLOGY LLC

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Oncodesign Services

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. North America Organoids Services Market Segmentation

Table 2. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Table 3. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type

Table 4. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application

Table 5. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source

Table 6. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country

Table 7. United States: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type

Table 8. United States: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 9. United States: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 10. Canada: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type

Table 11. Canada: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 12. Canada: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 13. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type

Table 14. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 15. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 16. Recent Organic Growth Strategies in Organoids Services Market

Table 17. Recent Inorganic Growth Strategies in the Organoids Services Market

Table 18. Glossary of Terms, Organoids Services Market

List of Figures

Figure 1. North America Organoids Services Market Segmentation - Country

Figure 2. PEST Analysis

Figure 1. Impact Analysis of Drivers and Restraints

Figure 2. North America Organoids Services Market Revenue (US$ Million), 2021-2031

Figure 3. North America Organoids Services Market Share (%) - by Type (2023 and 2031)

Figure 4. Intestine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 5. Liver: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 6. Stomach: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 7. Pancreas: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 8. Lung: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 9. Brain: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 10. Kidney: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 11. Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 12. North America Organoids Services Market Share (%) - by Application (2023 and 2031)

Figure 13. Developmental Biology Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 14. Pathology of Infectious Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 15. Regenerative Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 16. Drug Toxicity and Efficacy Testing: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 17. Drug Discovery and Personalized Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 18. Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 19. North America Organoids Services Market Share (%) - by Source (2023 and 2031)

Figure 20. Pluripotent Stem Cells: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 21. Organ Specific Adult Stem Cell: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 22. North America Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 23. United States: North America Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 24. Canada: North America Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 25. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 26. Growth Strategies in Organoids Services Market